![Cognition Therapeutics Inc](/common/images/company/N_CGTX.png)
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate, CT1812, is an o... Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate, CT1812, is an orally delivered, small molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 1.92 | 2.12 | 1.83 | 116036 | 1.93375356 | CS |
4 | -0.3 | -13.5135135135 | 2.22 | 2.22 | 1.61 | 154331 | 1.85920335 | CS |
12 | 0.06 | 3.22580645161 | 1.86 | 2.95 | 1.61 | 148545 | 2.03288708 | CS |
26 | -0.08 | -4 | 2 | 2.95 | 1.61 | 180398 | 2.02693295 | CS |
52 | 0.15 | 8.47457627119 | 1.77 | 2.95 | 0.9001 | 150098 | 1.84066285 | CS |
156 | -10.23 | -84.1975308642 | 12.15 | 13.8 | 0.9001 | 163654 | 3.01519805 | CS |
260 | -10.23 | -84.1975308642 | 12.15 | 13.8 | 0.9001 | 163654 | 3.01519805 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.